Search Results - M S Zainulina

Opportunities of using nadroparin calcium for prevention thrombotic complications at risk of coagulopathic bleeding by T. A. Sushko, M. S. Zainulina

Connect to this object online.

Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation by O. L. Mysik, M. S. Zainulina

Connect to this object online.

THE GOLDEN PAGES IN THE RUSSIAN HISTORY OF OBSTETRICS: FROM THE TIMES OF EKATERINE TO THE PRESENT by A. V. Loginov, M. S. Zainulina

Connect to this object online.

Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies by D. R. Eremeeva, M. S. Zainulina

Connect to this object online.

Application of the rotational thromboelastography/thromboelastometry for assessment of massive obstetric blood loss in a high risk group by D. R. Eremeeva, M. S. Zainulina

Connect to this object online.

Risks of reproductive loss and placenta-mediated pregnancy complications in women with antiphospholipid antibodies by Yu. S. Dolgova, D. R. Eremeeva, M. S. Zainulina

Connect to this object online.

Complications and outcomes of pregnancy in patients with antiphospholipid antibodies during various treatment methods by Yu. S. Bagdasarova, M. S. Zainulina, M. G. Nikolaeva

Connect to this object online.

ANTIPHOSPHOLIPID SYNDROME AND EARLY REPRODUCTIVE FAILURE by M. I. Krivonos, M. S. Zainulina, S. A. Selkov

Connect to this object online.

The role of magnesium drugs in the treatment of women with recurrent pregnancy loss when threatened with pregnancy termination by M S Zainulina, D R Eremeeva, E A Kornyushina

Connect to this object online.

MATERNAL MORTALITY AND MATERNAL «NEAR MISS»: ARE THE CURRENT BLEEDING PREVENTION ALGORITHMS WORKING? by M. S. Zainulina, D. R. Eremeeva, M. I. Krivonos

Connect to this object online.

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES by M. I. Krivonos, M. S. Zainulina, E. A. Kornyushina, S. V. Chepanov, S. A. Selkov

Connect to this object online.

What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas? by V. O. Bitsadze, M. S. Zainulina, J. Kh. Khizroeva, M. G. Nikolaeva, A. D. Makatsariya

Connect to this object online.

Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype) by M. G. Nikolaeva, A. P. Momot, M. S. Zainulina, K. A. Momot, N. N. Yasafova

Connect to this object online.

Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies by D. R. Eremeeva, M. S. Zainulina, Yu. S. Dolgova, R. A. Shakhaliev, O. A. Silvanovich, L. A. Pavlova

Connect to this object online.

Gestational complications of the prothrombin G20210A mutation related to prothrombin activity by M. G. Nikolaeva, N. N. Yasafova, A. P. Momot, M. S. Zainulina, K. A. Momot, I. A. Taranenko

Connect to this object online.

Regarding the evidence-based use of micronized progesterone by A. D. Makatsariya, G. C. Di Renzo, G. Rizzo, V. O. Bitsadze, J. Kh. Khizroeva, D. V. Blinov, E. I. Vovk, I. E. Govorov, D. L. Guryev, G. B. Dikke, M. S. Zainulina, N. S. Zakharova, V. V. Kovalev, E. V. Komlichenko, V. A. Kramarskiy, A. B. Loginov, L. I. Maltseva, V. B. Nemirovskiy, D. A. Ponomarev, E. B. Rudakova, N. V. Samburova, O. F. Serova, F. K. Tetelyutina, M. V. Tretyakova, J. Yu. Ungiadze, V. I. Tsibizova

Connect to this object online.